Craig-Hallum upgraded Cardlytics to Buy from Hold with a price target of $18, up from $10. The company reported an “impressive” quarter and guidance that sets the stage for improving fundamentals throughout 2024, the analyst tells investors in a research note. Cardlytics’ 2024 is off to a strong start with the return of Starbucks (SBUX), the addition of American Express (AXP) and the rollout of a new suite of real-time data reporting tools which has a been a sticking point for advertisers, the analyst tells investors in a research note. The firm sees the company’s billings accelerating in Q1 and improved top- and bottom-line numbers in 2024.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CDLX:
- Cardlytics Inc to Share Insightful Presentation for Investors
- Cardlytics Announces Fourth Quarter and Full Year 2023 Financial Results
- Cardlytics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Cardlytics Announces Timing of Its Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast
- Cardlytics, Inc. (CDLX) Q4 Earnings Cheat Sheet